跳至主要内容
临床试验/NCT06319859
NCT06319859已完成3 期

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries: A Randomized Controlled Clinical Trial.

Cairo University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年8月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Time to first analgesic requirement

研究概览

简要总结

This study will evaluate the efficacy and safety of intrathecal non-preservative-free morphine and its effect on pain in patients undergoing unilateral inguinal hernia surgeries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18-65 years old.
  • Both genders.
  • ASA I and II class.

排除标准

  • Patient refusal.
  • Known local anesthetic (LA) allergy.
  • Skin lesions or infections at the site of needle insertion.
  • Contraindications to spinal anesthesia.
  • Failure of spinal anesthesia.
  • ASA III and VI class.
  • Central or peripheral neuropathies.
  • Severe respiratory or cardiac diseases.

研究组 & 干预措施

Group A

Active Comparator

patients will receive 0.1 mg morphine with 15 mg heavy bupivacaine intrathecally

干预措施: Morphine (Drug)

Group B

Active Comparator

patients will receive 15 mg heavy bupivacaine with 0.1 ml saline intrathecally

干预措施: Placebo (Drug)

结局指标

主要结局

Time to first analgesic requirement

时间窗: 48 hours post-operatively

The time to first analgesic required by the patient will be recorded

次要结局

  • The incidence of other adverse effects(14 days post-operatively)
  • Nalbuphine consumption(48 hours post-operatively)
  • Postoperative pain(at 2, 4,8,12,18,24,30,36,42, and 48 hours post-operatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

AbdElKhalik Mahmoud Shaban

Lecturer of anaesthesia

Cairo University

研究点 (1)

Loading locations...

相似试验